Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Us
RecruitingNCT06969937Phase: PHASE2Started 2025-06-01
Summary
The goal of this clinical trial is to learn about the effects of the combination of ketamine and realtime functional magnetic resonance imaging (fMRI) neurofeedback training on the treatment of indivi
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Psychiatric University Zurich, University of ZurichZurich, Switzerland
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06969937